A detailed history of Garden State Investment Advisory Services LLC transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 52,000 shares of VIRI stock, worth $230,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,000
Holding current value
$230,880
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.17 - $0.29 $8,840 - $15,079
52,000 New
52,000 $8.84 Million

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Garden State Investment Advisory Services LLC Portfolio

Follow Garden State Investment Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garden State Investment Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garden State Investment Advisory Services LLC with notifications on news.